‘The Twilight Zone’ Adds ‘Silicon Valley’s Kumail Nanjiani

0

Kumail Nanjiani The Twilight Zone

CBS All Access announced Kumail Nanjiani will star in an episode of the upcoming revival of The Twilight Zone. The network didn’t confirm who Nanjiani will play or what episode he’ll be involved in. However, they did announce the episode with Nanjiani attached will be written by Alex Rubens (Key and Peele, The Last OG).

Kumail Nanjiani’s best known for his starring role in the critically acclaimed HBO half-hour comedy series, Silicon Valley. His credits also include Mike and Dave Need Wedding Dates, Portlandia, and Franklin & Bash.

Nanjiani’s autobiographical comedy/drama The Big Sick was nominated for a Best Original Screenplay Oscar. The film also picked up Screen Actors Guild Awards nominations in the Outstanding Performance by a Cast in a Motion Picture and Outstanding Performance by a Female Actor in a Supporting Role (Holly Hunter) categories. The Broadcast Film Critics Association nominated The Big Sick in their Best Supporting Actress, Best Original Screenplay, Best Actress in a Comedy, Best Picture, and Best Actor categories. The movie took home the Critics’ Choice Awards’ Best Comedy trophy.

Nanjiani joins Sanaa Lathan and Adam Scott in the CBS All Access series which has Jordan Peele hosting, narrating, and executive producing. The new The Twilight Zone is a CBS Television Studios production in association with Peele’s Monkeypaw Productions and Simon Kinberg’s Genre Films. Kinberg, Win Rosenfeld, Audrey Chon, Carol Serling, Rick Berg, and Greg Yaitanes are also executive producing.

A Look Back at The Twilight Zone, Courtesy of CBS:

“The original The Twilight Zone took viewers to another dimension, a dimension not only of sight and sound, but of mind. It was a journey into a wondrous land of imagination for five years on CBS, from 1959-1964. The godfather of sci-fi series, the show explored humanity’s hopes, despairs, prides and prejudices in metaphoric ways conventional dramas could not.”




Share.

Comments are closed.